These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9430409)

  • 1. Acute reserpine administration elicits long-term spontaneous oral dyskinesia.
    Sussman AN; Tran-Nguyen LT; Neisewander JL
    Eur J Pharmacol; 1997 Oct; 337(2-3):157-60. PubMed ID: 9430409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemical changes associated with the persistence of spontaneous oral dyskinesia in rats following chronic reserpine treatment.
    Neisewander JL; Lucki I; McGonigle P
    Brain Res; 1991 Aug; 558(1):27-35. PubMed ID: 1933381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent differences in the development of reserpine-induced oral dyskinesia in rats: support for a model of tardive dyskinesia.
    Neisewander JL; Castañeda E; Davis DA
    Psychopharmacology (Berl); 1994 Sep; 116(1):79-84. PubMed ID: 7862934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of age on reserpine-induced orofacial dyskinesia and possible protection of diphenyl diselenide.
    Burger M; Fachinetto R; Calegari L; Paixão MW; Braga AL; Rocha JB
    Brain Res Bull; 2004 Dec; 64(4):339-45. PubMed ID: 15561469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of age on a new animal model of tardive dyskinesia.
    Bergamo M; Abílio VC; Queiroz CM; Barbosa-Júnior HN; Abdanur LR; Frussa-Filho R
    Neurobiol Aging; 1997; 18(6):623-9. PubMed ID: 9461060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reserpine does not induce orofacial dyskinesia in spontaneously hypertensive rats.
    Queiroz CM; Piovezan RD; Frussa-Filho R
    Eur J Pharmacol; 1998 Sep; 356(2-3):105-8. PubMed ID: 9774239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of amphetamine and 6-hydroxydopamine lesions on reserpine-induced oral dyskinesia.
    Neisewander JL; Castañeda E; Davis DA; Elson HJ; Sussman AN
    Eur J Pharmacol; 1996 Jun; 305(1-3):13-21. PubMed ID: 8813526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of monosialoganglioside on a new model of tardive dyskinesia.
    Vital MA; Frussa-Filho R; Palermo-Neto J
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 Oct; 21(7):1169-79. PubMed ID: 9421829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of reserpine-induced orofacial dyskinesia and cognitive dysfunction by quercetin.
    Naidu PS; Singh A; Kulkarni SK
    Pharmacology; 2004 Feb; 70(2):59-67. PubMed ID: 14685008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mitochondrial toxin 3-nitropropionic acid aggravates reserpine-induced oral dyskinesia in rats.
    Calvente PR; Araujo CC; Bergamo M; Abilio VC; D'Almeida V; Ribeiro Rde A; Frussa FR
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):401-5. PubMed ID: 11822352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of gabaergic drugs on reserpine-induced oral dyskinesia.
    Peixoto MF; Araujo NP; Silva RH; Castro JP; Fukushiro DF; Faria RR; Zanier-Gomes PH; Medrano WA; Frussa-Filho R; Abílio VC
    Behav Brain Res; 2005 May; 160(1):51-9. PubMed ID: 15836900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral and neurochemical effects of chronic administration of reserpine and SKF-38393 in rats.
    Neisewander JL; Lucki I; McGonigle P
    J Pharmacol Exp Ther; 1991 May; 257(2):850-60. PubMed ID: 2033524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agmatine attenuates reserpine-induced oral dyskinesia in mice: Role of oxidative stress, nitric oxide and glutamate NMDA receptors.
    Cunha AS; Matheus FC; Moretti M; Sampaio TB; Poli A; Santos DB; Colle D; Cunha MP; Blum-Silva CH; Sandjo LP; Reginatto FH; Rodrigues AL; Farina M; Prediger RD
    Behav Brain Res; 2016 Oct; 312():64-76. PubMed ID: 27306571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute reserpine and subchronic haloperidol treatments change synaptosomal brain glutamate uptake and elicit orofacial dyskinesia in rats.
    Burger ME; Fachineto R; Alves A; Callegari L; Rocha JB
    Brain Res; 2005 Jan; 1031(2):202-10. PubMed ID: 15649445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical changes associated with chronic administration of typical antipsychotics and its relationship with tardive dyskinesia.
    Bishnoi M; Chopra K; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 2007 Apr; 29(3):211-6. PubMed ID: 17520104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The group II metabotropic glutamate receptor agonist, DCG-IV, alleviates akinesia following intranigral or intraventricular administration in the reserpine-treated rat.
    Dawson L; Chadha A; Megalou M; Duty S
    Br J Pharmacol; 2000 Feb; 129(3):541-6. PubMed ID: 10711353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallic acid decreases vacuous chewing movements induced by reserpine in rats.
    Reckziegel P; Peroza LR; Schaffer LF; Ferrari MC; de Freitas CM; Bürger ME; Fachinetto R
    Pharmacol Biochem Behav; 2013 Mar; 104():132-7. PubMed ID: 23313549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Hibiscus rosa sinensis on reserpine-induced neurobehavioral and biochemical alterations in rats.
    Nade VS; Dwivedi S; Kawale LA; Upasani CD; Yadav AV
    Indian J Exp Biol; 2009 Jul; 47(7):559-63. PubMed ID: 19761039
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Soung HS; Wang MH; Chang KC; Chen CN; Chang Y; Yang CC; Tseng HC
    Neurotox Res; 2018 Oct; 34(3):375-387. PubMed ID: 29629512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction.
    Naidu PS; Singh A; Kulkarni SK
    Phytother Res; 2006 Feb; 20(2):140-6. PubMed ID: 16444668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.